Jacobi Capital Management LLC Amgen Inc Transaction History

Jacobi Capital Management LLC

$1.29 Billion
Q3 2024

A detailed history of Jacobi Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Jacobi Capital Management LLC holds 10,745 shares of AMGN stock, worth $3.01 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

10,745

Previous 10,577 1.59%

Holding current value

$3.01 Million

Previous $3.3 Million 4.78%

% of portfolio

0.27%

Previous 0.29%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $51,975 - $56,679	168 Added 1.59%	10,745 $3.46 Million
Q2 2024 Aug 09, 2024	SELL	$262.75 - $319.31 $15,765 - $19,158	-60 Reduced 0.56%	10,577 $3.3 Million
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $198,157 - $239,200	737 Added 7.44%	10,637 $3.02 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $175,410 - $197,883	-686 Reduced 6.48%	9,900 $2.85 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $29,736 - $36,918	136 Added 1.3%	10,586 $2.85 Million
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $618,811 - $731,732	-2,888 Reduced 21.65%	10,450 $2.32 Million
Q1 2023 May 05, 2023	BUY	$225.79 - $275.2 $316,106 - $385,280	1,400 Added 11.73%	13,338 $3.22 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $30,231 - $38,413	-132 Reduced 1.09%	11,938 $3.14 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $12,120 - $13,670	-54 Reduced 0.45%	12,070 $2.72 Million
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $182,722 - $203,338	-792 Reduced 6.13%	12,124 $2.95 Million
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $16,445 - $18,192	75 Added 0.58%	12,916 $3.12 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $125,095 - $143,160	629 Added 5.15%	12,841 $2.89 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $251,539 - $294,709	1,185 Added 10.75%	12,212 $2.6 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $5,138 - $5,701	22 Added 0.2%	11,027 $2.69 Million
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $84,769 - $98,785	382 Added 3.6%	11,005 $2.74 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $125,067 - $148,933	578 Added 5.75%	10,623 $2.54 Million
Q3 2020 Oct 30, 2020	SELL	$234.65 - $260.95 $52,092 - $57,930	-222 Reduced 2.16%	10,045 $2.47 Million
Q2 2020 Aug 04, 2020	BUY	$197.81 - $242.74 $197 - $242	1 Added 0.01%	10,267 $2.49 Million
Q2 2020 Jul 27, 2020	BUY	$197.81 - $242.74 $23,341 - $28,643	118 Added 1.16%	10,266 $2.49 Million
Q1 2020 Apr 24, 2020	SELL	$182.24 - $241.7 $98,409 - $130,518	-540 Reduced 5.05%	10,148 $2.14 Million
Q4 2019 Feb 03, 2020	SELL	$189.21 - $243.2 $131,122 - $168,537	-693 Reduced 6.09%	10,688 $2.53 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $5,049 - $6,049	29 Added 0.26%	11,381 $2.23 Million
Q2 2019 Aug 07, 2019	BUY	$166.7 - $195.41 $718,310 - $842,021	4,309 Added 61.18%	11,352 $2.09 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $435,896 - $491,350	-2,410 Reduced 25.49%	7,043 $1.34 Million
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $19,624 - $22,907	110 Added 1.18%	9,453 $1.84 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $555 - $626	3 Added 0.03%	9,343 $1.94 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $56,789 - $63,786	342 Added 3.8%	9,340 $1.72 Million
Q1 2018 May 03, 2018	SELL	$169.43 - $198.0 $128,597 - $150,282	-759 Reduced 7.78%	8,998 $1.49 Million
Q4 2017 Feb 05, 2018	BUY	$168.79 - $188.59 $404,420 - $451,861	2,396 Added 32.55%	9,757 $1.76 Million
Q3 2017 Nov 02, 2017	BUY	$167.29 - $191.0 $928,459 - $1.06 Million	5,550 Added 306.46%	7,361 $1.37 Million
Q2 2017 Aug 10, 2017	BUY	N/A	1,811	1,811 $312,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobi Capital Management LLC with notifications on news.

Account

Jacobi Capital Management LLC Amgen Inc Transaction History